These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 30904991)

  • 1. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment.
    Ke Q; Zhao ZY; Griggs R; Wiley V; Connolly A; Kwon J; Qi M; Sheehan D; Ciafaloni E; Howell RR; Furu P; Sazani P; Narayana A; Gatheridge M
    World J Pediatr; 2017 Jun; 13(3):197-201. PubMed ID: 28466241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy.
    Wood MF; Hughes SC; Hache LP; Naylor EW; Abdel-Hamid HZ; Barmada MM; Dobrowolski SF; Stickler DE; Clemens PR
    Muscle Nerve; 2014 Jun; 49(6):822-8. PubMed ID: 24307279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for Duchenne muscular dystrophy: A two-year pilot study.
    Tavakoli NP; Gruber D; Armstrong N; Chung WK; Maloney B; Park S; Wynn J; Koval-Burt C; Verdade L; Tegay DH; Cohen LL; Shapiro N; Kennedy A; Noritz G; Ciafaloni E; Weinberger B; Ellington M; Schleien C; Spinazzola R; Sood S; Brower A; Lloyd-Puryear M; Caggana M;
    Ann Clin Transl Neurol; 2023 Aug; 10(8):1383-1396. PubMed ID: 37350320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States.
    Ross LF; Clarke AJ
    Pediatr Neurol; 2017 Dec; 77():12-22. PubMed ID: 29079012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal.
    Kwon JM; Abdel-Hamid HZ; Al-Zaidy SA; Mendell JR; Kennedy A; Kinnett K; Cwik VA; Street N; Bolen J; Day JW; Connolly AM
    Muscle Nerve; 2016 Aug; 54(2):186-91. PubMed ID: 27170260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy.
    Farrar MA; Kariyawasam D; Grattan S; Bayley K; Davis M; Holland S; Waddel LB; Jones K; Lorentzos M; Ravine A; Wotton T; Wiley V;
    J Neuromuscul Dis; 2023; 10(1):15-28. PubMed ID: 36373292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis newborn screening: a model for neuromuscular disease screening?
    Scully MA; Farrell PM; Ciafaloni E; Griggs RC; Kwon JM
    Ann Neurol; 2015 Feb; 77(2):189-97. PubMed ID: 25425541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon nanofiber-based multiplexed immunosensor for the detection of survival motor neuron 1, cystic fibrosis transmembrane conductance regulator and Duchenne Muscular Dystrophy proteins.
    Eissa S; Alshehri N; Abduljabbar M; Rahman AMA; Dasouki M; Nizami IY; Al-Muhaizea MA; Zourob M
    Biosens Bioelectron; 2018 Oct; 117():84-90. PubMed ID: 29890394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go.
    Dangouloff T; Vrščaj E; Servais L; Osredkar D;
    Neuromuscul Disord; 2021 Jun; 31(6):574-582. PubMed ID: 33985857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-year follow-up of newborn screening for patients with muscular dystrophy.
    Chung J; Smith AL; Hughes SC; Niizawa G; Abdel-Hamid HZ; Naylor EW; Hughes T; Clemens PR
    Muscle Nerve; 2016 Apr; 53(4):570-8. PubMed ID: 26260293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan.
    Chien YH; Lee NC; Weng WC; Chen LC; Huang YH; Wu CS; Hwu WL
    Neurol Sci; 2022 Jul; 43(7):4563-4566. PubMed ID: 35562557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy.
    Gruber D; Lloyd-Puryear M; Armstrong N; Scavina M; Tavakoli NP; Brower AM; Caggana M; Chung WK
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):197-205. PubMed ID: 36152336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy.
    Esposito G; Ruggiero R; Savarese M; Savarese G; Tremolaterra MR; Salvatore F; Carsana A
    Clin Chem Lab Med; 2013 Dec; 51(12):2239-45. PubMed ID: 23729582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands.
    Velikanova R; van der Schans S; Bischof M; van Olden RW; Postma M; Boersma C
    Value Health; 2022 Oct; 25(10):1696-1704. PubMed ID: 35963838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy.
    Ross LF
    Am J Med Genet A; 2006 Apr; 140(8):914-22. PubMed ID: 16528755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care.
    Armstrong N; Schrader R; Fischer R; Crossnohere N
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):162-168. PubMed ID: 35932090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.